期刊文献+

N-甲基-D-天冬氨酸受体信号通路及其介导的细胞凋亡机制研究进展 被引量:1

Advances in N-methyl-D-aspartate Receptor Signaling Pathway and Mechanism of the Pathway-mediated Apoptosis
下载PDF
导出
摘要 N-甲基-D-天冬氨酸受体(NMDAR)是重要的离子型谷氨酸受体,具有配体及电压双重门控离子通道特性,组成及功能复杂,分布广泛,在多种疾病或应激状态的病理生理进程中起着关键作用。其可通过线粒体及内质网损伤、活性氧与过氧亚硝酸盐生成、丝裂原活化蛋白激酶及钙蛋白酶激活等不同途径介导细胞凋亡。本文就NMDAR的结构分布、生物特性及其介导的信号通路在细胞凋亡中作用机制等方面进行综述。 N-methyl-D-aspartate receptor(NMDAR),an important ionic glutamate receptor and a ligand and voltage-gated ion channel characterized by complex composition and functions and wide distribution,plays a key role in the pathological and physiological process of diseases or stress states.NMDAR can mediate apoptosis through different pathways such as mitochondrial and endoplasmic reticulum damage,production of reactive oxygen species and peroxynitrite,and activation of mitogen-activated protein kinase and calpain.This paper reviews the structure,distribution,and biological characteristics of NMDAR and the mechanisms of NMDAR-mediated apoptosis.
作者 韩宜晓 侯雅竹 闫海峰 王帅 王贤良 毛静远 HAN Yixiao;HOU Yazhu;YAN Haifeng;WANG Shuai;WANG Xianliang;MAO Jingyuan(Department of Cardiology,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion,Tianjin 300381,China)
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2022年第1期149-157,共9页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(81904150) 天津市科技计划项目(15ZXLCSY00020) 教育部“创新团队发展计划”(IRT_16R54) 天津市中医药重点领域科研项目(2017002) 天津市研究生科研创新项目(2019YJSB142) 天津中医药大学研究生科研创新项目(YJSKC-20191018)。
关键词 N-甲基-D-天冬氨酸受体 信号通路 细胞凋亡 N-methyl-D-aspartate receptor signaling pathways apoptosis
  • 相关文献

参考文献5

二级参考文献141

  • 1Insel TR. Rethinking schizophrenia. Nature 2010, 468: 187-193.
  • 2Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, lzaki Y, et al. Predictors of subjective and objective quality of life in outpatients with schizophrenia. PsycbiatW Clm Nenrosci 2008, 62:404 -41 i.
  • 3Abi-Dargham A. Schizophrenia: overview and dopamine dysfnncrion. J Clin Psychiatry 2014, 75:e31.
  • 4Ross CA, Margolis RI., Reading SA, Plemikov M, Coyje Jr. Neumbiology of schizophrenia. Nem'on 2006, 52: 139-153.
  • 5Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RNI, tfefiler K, Sprengel R, et al. Mice lacking tile AMPA GIuR1 receptor ex- hibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry 2008, 13:631--640.
  • 6Wallen-Mackenzie A, Nordenankar K, Feigin K, Lagerstrom MC, Emilssun L, Fredriksson R, Wass C, et al. Restricted cortical and amygdal- old removal of vesicular glutamate transpnrter 2 in preadolescent mice im- pacts dopaminergic activity and neuronal circuitry of higher brain function. J Neurosci 2009, 29:2238-2251.
  • 7lnta D, Vogt MA, Perreau-Lenz S, Schneider M, Pfeiffer N, Wojcik SM, Spanagel R, et al. Sensorimotor gating, working and social memory defi- cits in mice with reduced expression of the vesicular glutamate transporter VGLUT1. Bebav Brabt Res 2012, 228: 328-332.
  • 8Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, Holmes A. Assessment of glutamate transporter GLAST (EAAT/)-deficient mice for pheuotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsycbopharmacology 2009, 34: 1578-1589.
  • 9Bondi C, Matthews M, Moghaddam B. Glutamatergic animal models of schizophrenia. Curr Pharm Des 2012, 18: 1593-1604.
  • 10Howes OD, Murray RM. Schizophrenia: an integrated suciodevelopmental- cognitive model. Lancet 2014, 383: 1677-1687.

共引文献19

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部